GRIPHON Open-Label Extension Study | UPTRAVI® (selexipag) HCP
Long-term health-related quality of life improvements among patients treated with lurasidone: results from the open-label extension of a switch trial in schizophrenia | BMC Psychiatry | Full Text
MARINE: Multi-Center, PlAcebo-Controlled, Randomized, Double-BlINd, 12- week study with an open-label Extension (NCT01047683) - Triglyceride Forum
Open label extension studies
An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis | Arthritis Research & Therapy | Full Text
Efficacy and Safety of Abatacept in Patients with Early Active Primary Sjögren's Syndrome – Open-label Extension Phase of a Randomized Controlled Phase III Trial - ACR Meeting Abstracts
Spotlight on Open-Label Extension Studies
Prolia® (denosumab) Open-Label Extension Study Design | Prolia®
Long-Term Safety and Efficacy of Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from the CLEAR Harmony Open-Label Extension Study) - American Journal of Cardiology
Open-label Extension Analysis – OCALIVA® (obeticholic acid) | Official US HCP Site
Patient disposition in REGAIN and the open-label study | Download Scientific Diagram
Understanding Clinical Trial Terminology: What is a Long-Term Extension or Open-Label Extension Study? - Concert Pharmaceuticals
image00002.jpg
Open Label Expansion – Athira Clinical Trials
Clinical Trial Design | Tavlesse® Chronic ITP Treatment
Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial - The Lancet Neurology
Study Design for PIONEER I and II, and Open-Label Extension | Download Scientific Diagram
Schematic view of an open label extension to a randomized controlled... | Download Scientific Diagram
HIV Incidence and Adherence in DREAM -An Open-Label Trial of Dapivirine Vaginal Ring - 2016 / 2018
What is TEGSEDI® (inotersen)? | MOA, Safety & Study Design
Prolia® (denosumab) Open-Label Extension Study Design | Prolia®
Version DD Month YYYY Guidance Doc Name Page X of Y Guidance Document Guidelines for Open Label Extensions Effective Review Ful
Study design schematic for the open-label extension study. AE, adverse... | Download Scientific Diagram
How to process data from clinical trials and their open label extensions PhUSE, Berlin, October 2010 Thomas Grupe and Stephanie Bartsch, Clinical Data. - ppt download
FOURIER Open Label Extension – TIMI STUDY GROUP
